Mesenchymal stem cell-derived inflammatory fibroblasts mediate interstitial fibrosis in the aging heart

JoAnn Trial1, Mark L Entman2, Katarzyna A Cieslik1

  • 1Division of Cardiovascular Sciences and the DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, TX, United States.

Insights

Aging heart fibrosis stems from stem cell dysfunction. Aged mesenchymal stem cells (MSCs) differentiate into inflammatory fibroblasts, secreting collagen and inflammatory factors, driving cardiac fibrosis.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Aging Research

Background:

  • Pathologic fibrosis in aging hearts is linked to resident mesenchymal stem cells (MSCs).
  • Aging impairs MSC stemness and promotes differentiation into dysfunctional inflammatory fibroblasts.
  • These aged fibroblasts contribute to cardiac fibrosis and inflammation.

Purpose of the Study:

  • To investigate the role of aging resident mesenchymal stem cells (MSCs) in cardiac fibrosis.
  • To identify molecular mechanisms driving fibroblast dysfunction in aging hearts.
  • To explore potential therapeutic targets for age-related cardiac fibrosis.

Main Methods:

  • Analysis of resident mesenchymal stem cells (MSCs) from aging mouse hearts.
  • Characterization of fibroblast differentiation and secretory profiles.
  • Investigation of the farnesyltransferase (FTase)-Ras-Erk pathway.

Main Results:

  • Aging MSCs exhibit reduced stemness and aberrant differentiation into inflammatory fibroblasts.
  • These fibroblasts secrete elevated collagen type 1 (Col1), monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6).
  • The FTase-Ras-Erk pathway mediates transcriptional activation of these fibrotic and inflammatory factors.
  • Defects are specific to cardiac MSCs, not bone wall MSCs (BW-MSCs).

Conclusions:

  • Dysfunctional aging cardiac MSCs drive fibrosis through inflammatory fibroblast activation.
  • The FTase-Ras-Erk pathway is a key regulator of this process.
  • Targeting this pathway may offer novel therapeutic strategies for age-related cardiac fibrosis.

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
4.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
568
Extracellular Matrix01:26

Extracellular Matrix

Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
6.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K